Appropriate use of immune checkpoint inhibitors and immunotherapy differs in adults with unresectable, metastatic cutaneous ...

A total of 92% of patients rated their satisfaction with phenol-croton peels as high, as rated as a score of 4 or 5 on the GSI.

The FDA biologics head Dr Vinay Prasad will step down in April following a tenure with controversial policy shifts and vaccine restrictions.

Eighteen states adopted cost-cutting changes to AIDS Drug Assistance Programs, potentially increasing HIV transmission and drug resistance.

Use of IPL therapy long-term is effective for improving facial outcomes in patients with rosacea, acne, or cosmetic concerns.

Doxycycline PEP reduces chlamydia risk but is associated with higher gonorrhea odds in a real-world study of a diverse clinic population.

The CDC's 2024 data showed a slight decline in US maternal mortality from 2023, continuing a downward trend after the pandemic.

Risankizumab is effective through 2.5 years of treatment among patients with psoriasis, with most patients achieving rapid and sustained response.

Use of a clinician-facing dashboard combined with a best practice alert helped increase rates of HLA-B*58:01 genetic testing among patients prescribed allopurinol.

The FDA has accepted a Biologics License Application for imsidolimab to treat generalized pustular psoriasis, a rare inflammatory skin condition.

An expected review of the United States’ measles elimination status has been postponed by seven months. The meeting, originally scheduled for mid-April, will ...

Litifilimab for 16 weeks was associated with improvements across various skin-specific outcomes compared with placebo in patients with CLE.